1. Introduction {#sec1}
===============

A 79-year-old man with a history of a right total hip arthroplasty (THA) performed 15 years prior to admission was admitted with 3 weeks of right hip pain. His history was notable for severe rheumatoid arthritis (RA), Alzheimer\'s dementia, coronary artery disease, and several arthroplasty revisions, which were performed 10 and 5 years prior to admission due to dislocations. His RA had been treated with prednisone 15 mg daily, leflunomide 10 mg daily, and infliximab. Six months prior to admission infliximab was replaced with abatacept 500 mg every month.

At presentation, vital signs were normal. BMI was 22.9 kg/m. He had right lower quadrant tenderness and pain with internal/external rotation of the right lower extremity. His WBC count was within normal limits. The CRP was 5.2 mg/L (normal \< 3 mg/L) and ESR was 28 mm/h (normal \< 15 mm/h). A CT scan of the abdomen and pelvis revealed complex fluid collections involving the right hip, buttock, and iliac fossa (see [Figure 1](#fig1){ref-type="fig"}). A joint aspirate contained 2734 cells/*μ*L WBC with 89% neutrophils. Aspirates from his joint and fluid collections were sent for Gram stain and culture, AFB smear and culture, and fungal cultures. Blood cultures were not sent. The AFB smears from each joint and fluid collection resulted positive for acid fast bacilli. The interferon gamma release assay (Quantiferon Gold) was indeterminate. HIV was not checked. His immunosuppression was adjusted, and leflunomide and abatacept were replaced with methotrexate and hydroxychloroquine. On day 14, mycobacterial cultures speciated as*Mycobacterium avium-intracellulare*(MAI). Rifampin, ethambutol, and clarithromycin were started.

A staged arthroplasty revision was not considered due to his comorbidities. Instead, he underwent extensive incision and drainage (I&D) of the joint and surrounding tissues, with percutaneous drain placement into the fluid collections. On discharge, he was continued on antimycobacterials for chronic suppression. After 4 months of therapy with ethambutol, clarithromycin, and rifampin, he continued to have positive AFB smears from the surgical site and percutaneous drains. After several months of declining quality of life, he was placed on hospice and died 6 months after initial presentation.

2. Discussion {#sec2}
=============

MAI (*M. avium* and*M. intracellulare*) are slow growing mycobacteria that typically cause human disease in the form of pulmonary infection among immunocompetent hosts, disseminated infection in the setting of HIV/AIDS, and cervical lymphadenitis \[[@B1]\]. Mycobacteria are a rare cause of prosthetic joint infection (PJI), making up 0--0.6% of cases, with the majority of these caused by*M. tuberculosis* \[[@B2], [@B3]\]. In one retrospective study of PJI caused by rapidly growing mycobacteria (RGM), only eight cases were identified over a 38-year time period, with the majority of cases occurring in immunocompetent hosts \[[@B4]\]. In contrast, PJI due to MAI occurs most often in immunocompromised hosts and is significantly rarer (see [Table 1](#tab1){ref-type="table"}) \[[@B2], [@B5]--[@B10]\]. To the best of our knowledge, this is the 7th reported case of PJI due to MAI and the first case in which the predisposing factor was immunosuppression due to antirheumatic medications.

In this patient, mycobacteria were likely introduced during a THA revision and persisted for years prior to disease onset in the setting of exogenous immunosuppression \[[@B11]\]. TNF-alpha antagonists, particularly infliximab, predispose patients to mycobacterial infections by blocking macrophage activation and intracellular killing \[[@B12]\]. The patient had risk factors both for PJI in general (RA, exogenous immunosuppressive medications) and for mycobacterial infection specifically, due to the use of multiple disease-modifying antirheumatic drugs (DMARDs). The use of oral corticosteroids and certain DMARDs such as TNF-alpha inhibitors and leflunomide increases the risk of both tuberculous and nontuberculous mycobacterial infections among patients with RA \[[@B13]\]. Abatacept has been associated with tuberculosis; however whether or not the drug is a risk factor for mycobacterial infection is unclear \[[@B14]\].

Making the diagnosis of NTM PJI requires obtaining mycobacterial cultures from clinical specimens in immunosuppressed patients at risk for NTM. Optimal management relies on experience from pulmonary MAI and PJI due RGM. A prolonged course of three drugs (macrolide, ethambutol, and rifampin) is recommended, in addition to surgical debridement or surgical excision \[[@B15]\]. Susceptibilities should be obtained to guide therapy. A case series of patients with PJI due to RGM suggested that resection arthroplasty with appropriate antimycobacterial drugs resulted in the best chance for cure. If debridement with prosthesis retention is performed, prolonged and indefinite antimycobacterial drugs are likely needed to prevent relapse \[[@B2], [@B4], [@B16]\]. Similar to PJI caused by rapid-growing NTM species, the prognosis for slow growing NTM PJI is variable (see [Table 1](#tab1){ref-type="table"}).

In conclusion, MAI is a rare cause of PJI, occurring almost exclusively in immunocompromised patients. Among patients with PJI taking DMARDs or other immunosuppressive biologic medications, a high index of suspicion is needed for opportunistic infections such as MAI. Ensuring multiple intraoperative specimens is sent for AFB smear/culture is imperative for diagnosis.
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###### 

Prosthetic joint infections caused by *Mycobacteriumavium* species.

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Citation     Age/gender   Pathogen             Site             Reason for arthroplasty       Predisposing factors                               Time to symptom onset                       Surgical treatment                                                           Medical treatment                                               Outcome
  ------------ ------------ -------------------- ---------------- ----------------------------- -------------------------------------------------- ------------------------------------------- ---------------------------------------------------------------------------- --------------------------------------------------------------- -----------------------------------------------------------------------------------------------------------
  \[[@B5]\]    67/F         MAC                  Hip              DJD                           Renal transplant on cyclosporine, prednisone       15 yrs after arthroplasty\                  I&D, removal of prosthesis, spacer placement\                                Azithromycin, ethambutol, rifabutin                             Planned reimplantation at 6 months and antimycobacterial coverage for total of 18 months
                                                                                                                                                    13 yrs after transplant                     Repeat I&D and spacer removal for sterile wound drainage 4 months post-op                                                                   

                                                                                                                                                                                                                                                                                                                                            

  \[[@B6]\]    41/M         MAI (disseminated)   Knee             Salmonella septic arthritis   Suspected underlying immunodeficiency syndrome\    15 mo after TKR (MRSA isolated after TKR)   Repeat debridements                                                          Multiple antibiotic regimens                                    Died due to sepsis with MRSA, *E.coli*, *K.pneumoniae*, MAI, *Candida* 7 months after initial MAI culture
                                                                                                 Polymyositis on prednisolone                                                                                                                                                                                                               

                                                                                                                                                                                                                                                                                                                                            

  \[[@B7]\]    NR           *M. avium*           Hip              Osteonecrosis                 Heart transplant on cyclosporine, prednisone       NR                                          None                                                                         Ethambutol, rifampin, isoniazid                                 Doing well at time of follow-up (time NR)

                                                                                                                                                                                                                                                                                                                                            

  \[[@B8]\]    20/M         MAC (disseminated)   Bilateral hips   Perthes disease               AIDS                                               20 yrs after arthroplasty\                  Right hip resection arthroplasty                                             Ciprofloxacin, clarithromycin, rifampicin, clofazimine          Died 5 months post-op
                                                                                                                                                   4 yrs after HIV diagnosis                                                                                                                                                                

                                                                                                                                                                                                                                                                                                                                            

  \[[@B9]\]    73/M         MAI (disseminated)   Knee             DJD                           Multiple myeloma on lenalidomide, dexamethasone\   3 yr after chemotherapy,\                   Resection arthroplasty (reimplantation 7 mo post-op)                         Clarithromycin, ethambutol                                      Doing well at 7 years of follow up
                                                                                                 RA on methotrexate\                                1 yr after arthroplasty                                                                                                                                                                 
                                                                                                 Previous pulmonary and olecranon MAC infections                                                                                                                                                                                            

                                                                                                                                                                                                                                                                                                                                            

  \[[@B10]\]   39/M         MAI (disseminated)   Hip              Osteonecrosis                 Renal transplant                                   NR                                          Resection arthroplasty                                                       Azithromycin, ethambutol \> 12 mo; did not tolerate rifabutin   No recurrence on ethambutol, clarithromycin; reimplantation of prosthesis not performed
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

DJD, degenerative joint disease; I&D, incision and drainage; MAC, *Mycobacteriumavium* complex; MAI, *Mycobacteriumavium*-*intracellulare*; mo, months; MRSA, methicillin-resistant *S. aureus*; NR, not reported; PCP, *Pneumocystis carinii* pneumonia; TKR, total knee replacement; yrs, years.
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